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• Offer a urine dipstick test to detect blood, glucose, 
protein, leucocytes, and nitrites.
• Offer the patient information and advice, and give 
him the time to decide whether he wishes to have 
prostate specific antigen testing if:
-His symptoms suggest bladder outlet obstruction 
secondary to benign prostatic enlargement or 
-His prostate feels abnormal on digital rectal 
examination or
-He is concerned about prostate cancer.
• Offer a serum creatinine test (plus calculation of 
estimated glomerular filtration rate) only if you 
suspect renal impairment (for example, if the man 
has a palpable bladder, nocturnal enuresis, recurrent 
urinary tract infections, or a history of renal stones).
• Refer for specialist assessment (in any setting by 
a healthcare professional with specific training 
in managing LUTS in men) if the symptoms are 
complicated by recurrent or persistent urinary 
tract infection, retention, renal impairment that 
is suspected to be caused by lower urinary tract 
dysfunction, or suspected urological cancer.
• Offer men considering any treatment for LUTS 
an assessment of their baseline symptoms with 
a validated symptom score (for example, the 
international prostate symptom score5 6) to allow 
assessment of subsequent changes in symptoms.
GuIdElInEs
Management of lower urinary tract symptoms in men: 
summary of nICe guidance
Clare Jones,1 Jennifer Hill,1 Christopher Chapple,1 2 on behalf of the Guideline Development Group
This is one of a series of BMJ 
summaries of new guidelines 
based on the best available 
evidence; they highlight 
important recommendations for 
clinical practice, especially where 
uncertainty or controversy exists
The supporting evidence 
statements and further 
information about the guidance 
are in the full version on bmj.com.
1National Clinical Guideline Centre 
for Acute and Chronic Conditions, 
Royal College of Physicians, 
London NW1 4LE
2Department of Urology, Royal 
Hallamshire Hospital, Sheffield 
Teaching Hospitals NHS 
Foundation Trust, Sheffield S10 2JF
Correspondence to: C Chapple 
c.r.chapple@sheffield.ac.uk 
Cite this as: BMJ 2010;340:c2354
doi: 10.1136/bmj.c2354
Lower urinary tract symptoms (LUTS) in men are related 
to problems with storage and voiding of urine and 
can occur after micturition. The many causes of LUTS 
include abnormalities or abnormal function of the blad-
der, prostate, urethra, or sphincters. The prevalence of 
LUTS increases as men get older, with about 30% of men 
aged 65 years and older having troublesome symptoms,1 
which may require treatment. This article summarises 
the most recent recommendations from the National 
Institute for Health and Clinical Excellence (NICE) on 
LUTS.2 
Recommendations
NICE recommendations are based on systematic reviews 
of best available evidence and explicit consideration of 
cost effectiveness. When minimal evidence is available, 
recommendations are based on the guideline develop-
ment group’s experience and opinion of what constitutes 
good practice. Evidence levels for the recommendations 
are in the full version of this article on bmj.com.   
Lower urinary tract symptoms have been categorised 
according to the three stages of the bladder cycle3: storage 
(when filling of the bladder occurs), voiding (when the 
bladder actively expels its contents), and post micturition 
(immediately after voiding, while returning to the storage 
stage) (box).
Initial assessment
At initial assessment (in any setting and by a healthcare 
professional without specific training in managing LUTS 
in men) take the following actions.
• Offer the patient an assessment of his general 
medical history to identify possible causes of LUTS 
and associated comorbidities; review current 
medication, including herbal and over the counter 
medicines (for example, Serenoa repens (saw 
palmetto) and pumpkin seed extract), to identify 
drugs that may be contributing to the problem.
• Offer a physical examination guided by urological 
symptoms and other medical conditions; an 
examination of the abdomen and external genitalia; 
and a digital rectal examination.
• Ask men with symptoms that interfere with quality 
of life to complete a “urinary frequency/volume 
chart,” recording the frequencies and volumes of 
fluid drunk and voided.4
Categories of lower urinary tract symptoms3
Storage (also symptoms of overactive bladder)
Urgency
Increased daytime frequency
Nocturia
Urinary incontinence
Voiding
Hesitancy
Straining
Slow stream
Splitting or spraying
Intermittency
Terminal dribble
Post-micturition
Post-micturition dribble
Feeling of incomplete emptying
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treatments (including transurethral needle ablation, 
transurethral microwave thermotherapy, high 
intensity focused ultrasound, transurethral ethanol 
ablation of the prostate, and laser coagulation) as 
alternatives to TURP, TUVP, or HoLEP, as there is 
insufficient evidence that these techniques offer any 
advantage over TURP.
Providing information
• Make sure men with LUTS have access to care 
that can help with their emotional and physical 
conditions and with relevant physical, emotional, 
psychological, sexual, and social issues.
• Advise men with storage symptoms (particularly 
incontinence) about relevant support groups.
Overcoming barriers
Lower urinary tract symptoms (storage, voiding, and 
postmicturition) can affect both men and women (see the 
recent NICE guidance on female incontinence7), and this 
guidance on male LUTS aims to dispel the stereotype that 
men have only obstructive symptoms whereas women 
have incontinence. Men tend to be slow to seek health 
advice, particularly with symptoms that may be consid-
ered sensitive. This guidance is aimed at (a) encouraging 
healthcare practitioners to recognise the impact of LUTS 
on quality of life; (b) overcoming any stigma related to 
these symptoms; and (c) highlighting for patients and 
healthcare professionals alike that symptoms can be 
managed effectively after simple initial assessment. To 
enable accurate categorisation of underlying problems 
of the lower urinary tract, the guidance recommends the 
routine use of a simple chart for recording the frequen-
cies and volumes of fluids drunk and voided. Use of the 
chart may show, for example, that urinary frequency is 
associated with drinking too much fluid or with underly-
ing comorbidity, rather than being caused by a disorder 
of the lower urinary tract.
Primary care lacks resources for managing lower uri-
nary tract symptoms, with not enough healthcare profes-
sionals specialising in this area. One way to overcome this 
could be to change reimbursement strategies, such as the 
quality and outcomes framework, to increase the incen-
tives to improve care.
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Conservative management
• Offer men with storage symptoms (particularly 
urinary incontinence) temporary containment 
products (for example, pads or collecting devices) so 
that they can contuinue their normal daily activities 
until a diagnosis and management plan have been 
discussed.
• If symptoms are not bothersome or complicated, 
reassure the patient by explaining the possible 
causes of these symptoms, offer advice on lifestyle 
interventions (for example, adjusting fluid intake) 
and information on their condition. Offer a review if 
symptoms change.
• For men with symptoms suggestive of an overactive 
bladder (see box), offer supervised bladder training 
(which aims to reduce urgency and urinary 
frequency through a gradual increase in the 
intervals between urination episodes), advice on 
fluid intake, lifestyle advice (for example, caffeine 
and alcohol reduction), and if needed containment 
products.
Drug treatment 
• For men with moderate to severe symptoms, offer 
an α blocker (alfuzosin, doxazosin, tamsulosin, or 
terazosin).
• For men with symptoms of an overactive bladder, 
offer an anticholinergic.
Specialist assessment
Specialist assessment refers to the assessment carried out 
in any setting by a healthcare professional with specific 
training in managing LUTS in men.
• For men with complicated symptoms or bothersome 
symptoms that have not responded to conservative 
management or drug treatment, offer referral for 
specialist assessment.
• Offer cystoscopy to those having specialist 
assessment only when clinically indicated—for 
example, if the patient has a history of recurrent 
infection, sterile pyuria, haematuria, severe 
symptoms, or pain.
• Offer imaging of the upper urinary tract to those 
having specialist assessment only when clinically 
indicated—for example, if the patient has a history 
of chronic retention, haematuria, recurrent 
infection, sterile pyuria, severe symptoms, or pain.
Surgery for voiding symptoms
• If offering surgery for managing voiding symptoms 
that are presumed secondary to benign prostatic 
enlargement, offer monopolar or bipolar 
transurethral resection of the prostate (TURP), 
monopolar transurethral vaporisation of the 
prostate (TUVP), or holmium laser enucleation of 
the prostate (HoLEP). Perform HoLEP at a centre 
that specialises in the technique or has mentorship 
arrangements.
• If offering surgery for managing voiding symptoms 
that are presumed secondary to benign prostatic 
enlargement, do not offer minimally invasive 
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Resisting the temptation to attach a diagnostic 
label to indeterminate symptoms can be in the 
patient’s interests
Case scenario
A 38 year old woman presented with “indigestion type” 
symptoms. She had a long history of frequent visits to 
her general practitioner (GP) and investigations for unex-
plained pelvic pain, dizziness, and headache. On this occa-
sion she felt a “burning” sensation “in a band across my 
tummy” and felt as though the ground was unsteady when 
she walked. Her GP could reach no diagnosis and said he 
believed her symptoms were likely to resolve, advising 
follow-up in a few weeks.
diagnostic labels
A “diagnostic label” in general practice is generally a work-
ing diagnosis that functions as a decision node. It is dif-
ferent from the histologically or microbiologically proved 
diagnoses made in secondary care and tends to take one 
of three forms:
• A working diagnosis on which treatment is based 
(such as “acute otitis media”)
• A working diagnosis on which further investigations 
are planned (such as “bloody diarrhoea ? 
inflammatory bowel disease”)
• A working diagnosis indicating the absence of serious 
disease (such as “calf pain, not DVT”).
The aim of this article is to understand why diagnostic 
labels are sometimes not applied in general practice con-
sultations and to understand how this approach contri-
butes to making decisions about diagnoses.
This series aims to set out 
a diagnostic strategy and 
illustrate its application with 
a case. The series advisers are 
Kevin Barraclough, general 
practitioner, Painswick, and 
research fellow in community 
based medicine, University of 
Bristol; Paul Glasziou, professor 
of evidence based medicine, 
Department of Primary Health 
Care, University of Oxford; and 
Peter Rose, university lecturer, 
Department of Primary Health 
Care, University of Oxford.
Why is a diagnosis sometimes missing?
Bruce Thomas, a general practitioner in Hampshire, UK, 
pointed out in the 1970s that in up to 40% of patients in 
general practice no diagnostic label could be attached.1 2 
These patients did not require, and generally were not 
given, specific treatment, and most recovered spontane-
ously. This remains the case. In a 2005 review of consul-
tation data in the UK, “symptoms, signs and ill-defined 
conditions” was the computer coded group of disorders 
presenting most frequently in general practice.3
Also in the 1970s, Howie described “the relative rarity 
of fully developed hospital illness” in general practice. He 
pointed out that using the same diagnostic terminology 
in general practice as was used in hospitals could some-
times be misleading because of the “different spectrum of 
disease” and the different level of diagnostic certainty in 
primary care.4 In primary care, diagnostic labels can give 
spurious and erroneous diagnostic precision when what is 
being managed is what Howie described as a symptom:sign 
complex (such as non-cardiac chest pain with mild local-
ised chest wall tenderness).
When is management without a diagnostic label used?
For many patients in general practice, the diagnostic strate-
gies described by Heneghan et al (figure) are appropriate.5 
When pattern recognition and iterative diagnosis6 do not 
give an answer, when symptoms are vague, or when a clear 
diagnosis does not “crystallise” from investigations or tests 
Initiation of
the diagnosis
Stage Strategy
• Spot diagnoses
• Self labelling 
• Presenting complaint
• Pattern recognition trigger
Refinement
• Restricted rule-outs
• Stepwise refinement
• Probabilistic reasoning
• Pattern recognition fit
• Clinical prediction rule
Defining the
final diagnosis
• Known diagnosis
• Further tests ordered
• Test of treatment
• Test of time
• No label applied
Stages and strategies in arriving at a diagnosis
KEy POInTs
Some patients who present in primary care cannot be given a definite diagnostic label
Not giving a diagnostic label may indicate to the patient that nothing serious is wrong or may 
leave the door open for further investigation and clarification of symptoms
A definite, final diagnosis cannot be made in a large proportion of patients presenting with 
physical symptoms
Patients falling into the spectrum of medically unexplained physical symptoms (MUPS) are 
likely to require particularly skilful management
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include patients with so called medically unexplained physi-
cal symptoms (MUPS), which comprise conditions such as 
dizziness, temporomandibular joint dysfunction, fibromy-
algia, pelvic pain, “functional” abdominal pain, dyspepsia, 
and non-cardiac, non-reflux chest and thoracic pain. These 
patients present particular challenges for long term manage-
ment, because they generally attend often and generate high 
healthcare costs, through over-investigation and inappro-
priate referral. From time to time clinicians may encounter 
patients with definite physical symptoms, such as haema-
turia or haemoptysis, in whom no definite diagnosis can be 
made. In a cohort study of patients with alarm symptoms in 
primary care, GPs did not make a diagnosis in over 60% of 
37 000 patients.10
Case study
The following week, the 38 year old patient consulted her 
out of hours service and was given a prescription for a pro-
ton pump inhibitor for a presumed diagnosis of indigestion. 
Next morning she telephoned the surgery asking for a sick 
note as she was unable to get to work.
How does diagnosis go wrong?
Misdiagnosis can occur in two directions. Firstly, the doc-
tor may conclude incorrectly that a patient does not have a 
condition to which a diagnostic label should be attached, 
or for which treatment is needed, and hence allow undi-
agnosed symptoms to persist, such as gastro-oesophageal 
reflux causing “non-cardiac” chest pain or chronic cough. 
Conversely, the doctor may confer a formal diagnosis on the 
patient’s symptoms, despite the absence of adequate evi-
dence of a recognisable medical disorder, such as making a 
diagnosis of vertebrobasilar insufficiency in a patient with 
vague unsteadiness. A sense of pressure to make a specific 
diagnosis can come from patients, from fear of litigation if 
a disease is missed,11 or from the expected role of general 
practitioners as identifiers of disease.12
Wrong diagnoses in primary care can be caused by atypi-
cal and non-specific presentations, very rare conditions, and 
comorbidity, and also perceptual factors such as failure to 
observe subtle changes in colour or contour or abnormal 
swellings13 or gradual changes over time, as sometimes 
happens with patients with hypothyroidism or acromegaly. 
Other causes are shown in the box.
How can we improve?
Clinicians need to understand the various ways in which 
diagnostic labels should and should not be applied to 
patients in general practice, and they should be prepared to 
deal with the potential causes of diagnostic error listed in the 
box. This has important implications for medical education: 
performing clinical investigations and looking for symptoms 
and signs need to be taught with a probabilistic approach 
to differential diagnoses. Spuriously accurate clinical diag-
noses need to be discouraged, keeping in mind that patients 
benefit from a certainty of approach.
Managing unexplained symptoms requires a high qual-
ity relationship between doctor and patient, characterised 
by a sympathetic and empathic inquiry into the psychoso-
cial background of symptoms as well as the provision of 
considerable emotional support. Patients with medically 
of time or of treatment, patients will need to be managed 
without having a diagnostic label. In not applying a diag-
nostic label the clinician may be “leaving the door open” for 
further investigations if symptoms persist. Alternatively, the 
lack of a label may be part of letting the patient know that, 
as far as can be ascertained, their symptoms do not add up 
to anything substantial or serious. Many patients to whom 
no diagnostic label can be attached can be managed without 
treatment or further investigation.
In the 1980s Thomas examined patient satisfaction in 
200 consultations with patients who had symptoms but 
no abnormal physical signs. The patients were randomised 
to receive either a “positive” consultation (when they were 
given a firm diagnosis and told they would be better in a 
few days) or a “negative” consultation (in which no spe-
cific diagnosis or assurance was given), and also to receive 
either thiamine hydrochloride as a placebo or no treat-
ment. Two weeks after the consultation 64% of those who 
were managed with a positive consultation reported being 
recovered as opposed to 39% of those given no assurances.7 
The placebo drug treatment made little difference. This is 
consistent with a recent review of the placebo effect, which 
attributed the efficacy of the placebo to the overall content 
of the therapeutic interaction (doctor, patient, and context) 
rather than to any psychological effect that is specific to the 
(therapeutically inert) pill.8 Thomas’s study suggests that 
taking a positive attitude in the consultation may acceler-
ate patients’ spontaneous recovery from a vague symptom 
complex. Many patients without an obvious diagnostic label 
could be managed in this way.
The remaining patients, those with persistent symptoms 
still requiring investigation, contain three subgroups:
• Those with important diagnoses that have not yet been 
made, which may be rare or are easily missed,9 such as 
Addison’s disease, coeliac disease, and cancer of the 
ovary or pancreas
• Those with new or emerging conditions, such as 
obstructive sleep apnoea or chronic cough from gastro-
oesophageal reflux disease (many of whom were 
previously labelled as having “psychogenic cough”)
• Those with persisting symptoms whose physical basis 
is unclear.
The last (and largest) group will often have been exten-
sively investigated for poorly defined, often painful, 
conditions that are often associated with apparently dis-
proportionate effects on mood and general wellbeing. These 
Causes of wrong diagnoses in primary care
Cognitive oversight—simply not thinking of the correct diagnosis14—for example, forgetting 
coeliac disease as a cause of iron deficiency anaemia
Failure to gather adequate data—for example, inadequate physical examination for lower bowel 
symptoms caused by colorectal cancer
Misinterpretation of data—for example, diagnosing gout on the basis of a raised serum urate 
concentration or excluding it on the basis of normal serum urate.
Anchoring—sticking to an initial diagnosis despite disconfirming evidence,15 such as treating 
fatigue as depression despite evidence of abnormal renal function
Inappropriate confirmation—selective use of evidence to confirm an incorrect diagnosis, such 
as attributing importance to minor abnormalities in laboratory tests as an explanation for 
fatigue in someone with depression
Premature closure—arriving at a conclusive diagnosis before collecting all the data,16 such as 
diagnosing intermittent (vascular) claudication in a patient with lumbar canal spinal stenosis
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unexplained symptoms are no more likely than those with 
explained symptoms to seek explanation, reassurance, or 
somatic interventions such as special investigations, drug 
treatment, or specialist referral—but they are much more 
likely to seek emotional support from their clinician.17 They 
are also more likely to be cautious about the extent to which 
clinicians will take their problems seriously.18 19 Clinicians 
may manage these patients more effectively if they explain 
the limited, and potentially negative, value of repeat inves-
tigations, and if they avoid premature closure by regularly 
reviewing previous diagnostic labels or apparent lack of 
such labels. Clinicians may avoid unfounded diagnoses 
and subsequent somatic interventions by getting patients to 
talk about their social and psychological problems.20 21 Brief 
educational interventions, including didactic sessions, small 
group work, and role play with video feedback can increase 
GPs’ awareness of medically unexplained symptoms.22
Case study
The general practitioner asked the woman to return for 
review. A careful history elicited a description of a superficial 
“burning sensation” across the lower chest and increasing 
difficulty in walking. A Romberg test was positive, and she 
had increased tone and hyper-reflexia in her legs. Admission 
and magnetic resonance imaging of her neck showed a cen-
tral cervical disc prolapse causing a myelopathy.
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Below is a random sampling of remarkable investigation 
results, diagnostic studies, and experiences shared by our 
medicine residents over the past few years which appear 
on our “wall of fame.” Our wall functions as a portal for 
the education, team building, and bonding that is core to 
the successful development and acculturation of young 
physicians. The remarkable facts on the wall pique curiosity 
and inspire a healthy competition, with our residents taking 
pride in raising the bar by updating or adding to its content.
Highest fever: 109°F
Highest blood pressure: 309/166
Most coronary care unit admissions in 24 hours: 17
Most codes [cardiac arrest calls] on the same patient during 
one shift: three
Highest number of cross coverage calls in 10 hours: 81
Lowest ionised calcium: 0.40 mmol/l
Highest glucose on first day of internship: 2300 mg/dl 
Highest Pco2: 170 mm Hg
Highest non-haemolysed potassium: 18 mmol/l “alive and 
kicking”
Highest NT-proBNP [brain natriuretic peptide]: 348 000 pg/ml
Highest blood urea nitrogen: 354 mg/dl 
Lowest haemoglobin in an ambulatory patient: 1.6 g/dl
Highest sodium: 187 mmol/l
Highest blood alcohol: 680 mg/dl
Lowest temperature: 81°F
Oldest patient: 107 years
Oldest surgical patient: 102 years
Highest INR: 33
Highest furosemide dose: 480 mg daily
Lowest number of pages [bleeps] on a night float shift: three
Highest thyroid stimulating hormone: 743.60 mIU/ml
Highest parathyroid hormone, intact: 1912 pg/ml
Highest ammonia level: 700 μmole/l
Heaviest patient: 749 lb [340 kg, 53 st 7 lb]
Oldest patient requesting sildenafil: 85 years
Lowest high density lipoprotein: 5 mg/dl
Highest white blood cell count: 629 800×103/mm3
Highest H/H [haemoglobin and haematocrit]: 26.7 g/dl/75.3%
Longest QTc interval on electrocardiogram: 625 ms
Furthest discharge destination: Ukraine.
Michael J Rosenblum medical director, Baystate Medical Center, 
Springfield, USA michael.rosenblum@bhs.org
Cite this as: BMJ 2010;340:c421
The wall of fame
